These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34371178)

  • 41. Early production of IL-17 protects against acute pulmonary Pseudomonas aeruginosa infection in mice.
    Liu J; Feng Y; Yang K; Li Q; Ye L; Han L; Wan H
    FEMS Immunol Med Microbiol; 2011 Mar; 61(2):179-88. PubMed ID: 21204996
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of pulmonary and systemic bacterial lipopolysaccharide responses in transgenic mice expressing human elafin.
    Sallenave JM; Cunningham GA; James RM; McLachlan G; Haslett C
    Infect Immun; 2003 Jul; 71(7):3766-74. PubMed ID: 12819058
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of adenovirus-mediated elafin transgene expression by bacterial lipopolysaccharide.
    Simpson AJ; Cunningham GA; Porteous DJ; Haslett C; Sallenave JM
    Hum Gene Ther; 2001 Jul; 12(11):1395-406. PubMed ID: 11485631
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ASC acts in a caspase-1-independent manner to worsen acute pneumonia caused by Pseudomonas aeruginosa.
    Hughes AJ; Knoten CA; Morris AR; Hauser AR
    J Med Microbiol; 2018 Aug; 67(8):1168-1180. PubMed ID: 29957172
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of alginate-producing Pseudomonas aeruginosa on alveolar macrophage apoptotic cell clearance.
    McCaslin CA; Petrusca DN; Poirier C; Serban KA; Anderson GG; Petrache I
    J Cyst Fibros; 2015 Jan; 14(1):70-77. PubMed ID: 25027418
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interleukin 4 Deficiency Reverses Development of Secondary Pseudomonas aeruginosa Pneumonia During Sepsis-Associated Immunosuppression.
    Song Z; Zhang J; Zhang X; Li D; Wang H; Xu X; Xu W; Yin Y; Cao J
    J Infect Dis; 2015 May; 211(10):1616-27. PubMed ID: 25489003
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pulmonary inflammation induced by bacteria-free outer membrane vesicles from Pseudomonas aeruginosa.
    Park KS; Lee J; Jang SC; Kim SR; Jang MH; Lötvall J; Kim YK; Gho YS
    Am J Respir Cell Mol Biol; 2013 Oct; 49(4):637-45. PubMed ID: 23713467
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cystic fibrosis lung disease following infection with Pseudomonas aeruginosa in Cftr knockout mice using novel non-invasive direct pulmonary infection technique.
    Guilbault C; Martin P; Houle D; Boghdady ML; Guiot MC; Marion D; Radzioch D
    Lab Anim; 2005 Jul; 39(3):336-52. PubMed ID: 16004694
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of high-mobility group box 1 protein (HMGB1) enhances bacterial clearance and protects against Pseudomonas Aeruginosa pneumonia in cystic fibrosis.
    Entezari M; Weiss DJ; Sitapara R; Whittaker L; Wargo MJ; Li J; Wang H; Yang H; Sharma L; Phan BD; Javdan M; Chavan SS; Miller EJ; Tracey KJ; Mantell LL
    Mol Med; 2012 May; 18(1):477-85. PubMed ID: 22314397
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic stem cell-derived alveolar-like macrophages display bactericidal effects and resolve Pseudomonas aeruginosa-induced lung injury.
    Bouch S; Litvack ML; Litman K; Luo L; Post A; Williston E; Park AJ; Roach EJ; Berezuk AM; Khursigara CM; Post M
    J Cell Mol Med; 2022 May; 26(10):3046-3059. PubMed ID: 35441437
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Absence of Toll-like receptor 7 protects mice against Pseudomonas aeruginosa pneumonia.
    Xu H; Huang L; Luo Q; Tu Q; Liu J; Yu R; Huang J; Chen T; Yin Y; Cao J
    Int Immunopharmacol; 2021 Jul; 96():107739. PubMed ID: 33984723
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Estrogen aggravates inflammation in Pseudomonas aeruginosa pneumonia in cystic fibrosis mice.
    Wang Y; Cela E; Gagnon S; Sweezey NB
    Respir Res; 2010 Nov; 11(1):166. PubMed ID: 21118573
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Macrophages directly contribute to the exaggerated inflammatory response in cystic fibrosis transmembrane conductance regulator-/- mice.
    Bruscia EM; Zhang PX; Ferreira E; Caputo C; Emerson JW; Tuck D; Krause DS; Egan ME
    Am J Respir Cell Mol Biol; 2009 Mar; 40(3):295-304. PubMed ID: 18776130
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-inflammatory effect of pre-elafin in lipopolysaccharide-induced acute lung inflammation.
    Vachon E; Bourbonnais Y; Bingle CD; Rowe SJ; Janelle MF; Tremblay GM
    Biol Chem; 2002; 383(7-8):1249-56. PubMed ID: 12437112
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of recombinant human elafin in the resistance of A549 cells against Pseudomonas aeruginosa biofilm.
    Li Q; Zhou X; Nie X; Yang J
    Respiration; 2010; 79(1):68-75. PubMed ID: 19420899
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intradermal vaccination with a Pseudomonas aeruginosa vaccine adjuvanted with a mutant bacterial ADP-ribosylating enterotoxin protects against acute pneumonia.
    Baker SM; Pociask D; Clements JD; McLachlan JB; Morici LA
    Vaccine; 2019 Feb; 37(6):808-816. PubMed ID: 30638799
    [TBL] [Abstract][Full Text] [Related]  

  • 57. IFN regulatory factor 3 contributes to the host response during Pseudomonas aeruginosa lung infection in mice.
    Carrigan SO; Junkins R; Yang YJ; Macneil A; Richardson C; Johnston B; Lin TJ
    J Immunol; 2010 Sep; 185(6):3602-9. PubMed ID: 20720199
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Pseudomonas aeruginosa type III secretion system has an exotoxin S/T/Y independent pathogenic role during acute lung infection.
    Galle M; Jin S; Bogaert P; Haegman M; Vandenabeele P; Beyaert R
    PLoS One; 2012; 7(7):e41547. PubMed ID: 22844497
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prostaglandin E2-induced changes in alveolar macrophage scavenger receptor profiles differentially alter phagocytosis of Pseudomonas aeruginosa and Staphylococcus aureus post-bone marrow transplant.
    Domingo-Gonzalez R; Katz S; Serezani CH; Moore TA; Levine AM; Moore BB
    J Immunol; 2013 Jun; 190(11):5809-17. PubMed ID: 23630358
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gene complementation of airway epithelium in the cystic fibrosis mouse is necessary and sufficient to correct the pathogen clearance and inflammatory abnormalities.
    Oceandy D; McMorran BJ; Smith SN; Schreiber R; Kunzelmann K; Alton EW; Hume DA; Wainwright BJ
    Hum Mol Genet; 2002 May; 11(9):1059-67. PubMed ID: 11978765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.